CRISPR-Cas9 is a recent and revolutionary technique, as it is possible to perform gene editing specifically in the region of interest, which in this study was MMP-9, and evaluate the evolution of the tumor for a longer period, without stimulating all the adjacent effects of current treatments. Here, MMP9 is linked to neoplasm.